Why US approval for 'game changing' Alzheimer's drug is a step towards better treatment

Analysis

Lecanemab is the first medicine proven to slow the course of Alzhemier’s, although regulators have issued a safety warning about its side effects In a decision hailed as a “major step” towards improving treatment for patients, US regulators have approved the “game changing” Alzheimer’s drug lecanemab.

But it is being hailed as a game changer because it is the first medicine proven to slow the course of the disease – withAlthough UK-based scientists welcomed the decision in the US, they also warned against raising expectations surrounding who will benefit from the drug and by how much. People with more advanced forms of the disease may not benefit from the drug and may face increased safety risks.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Why some people are more likely to get early onset Alzheimer'sHow your genes could put you at risk for Alzheimer’s There are thousands of genetic variants that can raise your risk of the disease, explains StuartJRitchie - and there’s evidence that people with more of these genetic risks will develop it earlier
Source: i newspaper - 🏆 8. / 89 Read more »